JPMorgan Upgrades Charles River Labs (CRL) to Overweight
FREE Breaking News Alerts from StreetInsider.com!
- xBox One and PS4 Could Add $9B in Revenue for AMD (AMD) - Jefferies
- No Excuses: Home Depot (HD) Stole Business from Lowe's (LOW) in Q1
- Needham & Company Boosts PT on Pandora (P), Sees 23% Upside
- The ExOne Company (XONE) Metal Opportunity to Keep Stock Going - FBR
- Is 3D System (DDD) Going to Split its Stock Again?
Wells Fargo Upgrades Charles River Labs (CRL) to Outperform on Major Sell-Off
December 13, 2012 7:01 AM ESTWells Fargo upgraded Charles River Labs (NYSE: CRL) from Market Perform to Outperform with a valuation range of $40-$42, saying shares are oversold following Wednesday's 9% swoon on guidance.
The firm comments, "We are upgrading shares of CRL to Outperform from Market Perform following the company's 2013... More
Charles River Labs (CRL) Guides FY13 EPS Below Views
December 12, 2012 7:34 AM ESTCharles River Laboratories International, Inc. (NYSE: CRL) provided guidance for 2013 and reaffirmed guidance for 2012.
James C. Foster, Chairman, President and Chief Executive Officer, said, The actions we have taken in the last three years to enhance our in vivo biology portfolio, improve our operating efficiency, and forge stronger... More
